Stephanie Becourt

Lille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Clinical outcomes and prognostic factors in advanced high-grade platinum-resistant ovarian carcinoma: evidence from the ESME real-world cancer database.

Clinical outcomes and prognostic factors in advanced high-grade platinum-resistant ovarian carcinoma: evidence from the ESME real-world cancer database.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 15, 2026

Management of cancer treatment-related fatigue in advanced breast cancer patients: an expert committee's opinion.

Management of cancer treatment-related fatigue in advanced breast cancer patients: an expert committee's opinion.

Journal: Frontiers in oncology

Published: April 24, 2025

ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safety.

ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safety.

Journal: Gynecologic oncology

Published: January 11, 2025

Brain metastases in breast cancer: Diagnosis and management

Brain metastases in breast cancer: Diagnosis and management

Journal: Bulletin du cancer

Published: December 20, 2024

Is there a place for prophylactic fimbriectomy followed by delayed ovariectomy?

Is there a place for prophylactic fimbriectomy followed by delayed ovariectomy?

Journal: Bulletin du cancer

Published: June 12, 2024

Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer.

Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer.

Journal: British journal of cancer

Published: March 31, 2024

Breast Cancer Prognosis in Young BRCA1/BRCA2 Mutation Carriers: A Retrospective Hospital-based Cohort Study.

Breast Cancer Prognosis in Young BRCA1/BRCA2 Mutation Carriers: A Retrospective Hospital-based Cohort Study.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: February 28, 2024

Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.

Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.

Journal: Gynecologic oncology

Published: November 21, 2022

The promising prognostic value of vagal nerve activity at the initial management of ovarian cancer.

The promising prognostic value of vagal nerve activity at the initial management of ovarian cancer.

Journal: Frontiers in oncology

Published: September 21, 2022

Prognostic impact of tumor size reduction assessed by magnetic resonance imaging after radiochemotherapy in patients with locally advanced cervical cancer.

Prognostic impact of tumor size reduction assessed by magnetic resonance imaging after radiochemotherapy in patients with locally advanced cervical cancer.

Journal: Frontiers in oncology

Published: September 16, 2022

Tumor-Infiltrating Lymphocytes (TILs) in Epithelial Ovarian Cancer: Heterogeneity, Prognostic Impact, and Relationship with Immune Checkpoints.

Tumor-Infiltrating Lymphocytes (TILs) in Epithelial Ovarian Cancer: Heterogeneity, Prognostic Impact, and Relationship with Immune Checkpoints.

Journal: Cancers

Published: September 06, 2022

Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision-a Literature Review.

Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision-a Literature Review.

Journal: Current oncology reports

Published: June 30, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026